NDC 0310-1830-85
FASENRA 30 mg/mL
Benralizumab · INJECTION, SOLUTION
Fasenra is a prescription injection used to treat moderate to severe eosinophilic asthma in adult and pediatric patients. It works by blocking a specific immune pathway that reduces eosinophils, a type of white blood cell involved in asthma inflammation.
Key Facts
- Brand Name
- FASENRA
- Generic Name
- Benralizumab
- NDC Code (Package)
0310-1830-85- NDC Code (Product)
0310-1830- Manufacturer
- AstraZeneca Pharmaceuticals LP
- Strength
- 30 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761070
- Drug Class
- Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]
- Marketing Start
- 10/04/2019
Recall History
No Recall HistoryView Full Drug Page
FASENRA — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.